ICD-10-CM Code For Malignant Neuroendocrine Tumors: Group Overview
The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group C7A includes malignant neuroendocrine tumors, covering neoplasms of neuroendocrine cells that may arise in organs such as the pancreas, gastrointestinal tract, and respiratory system and that are characterized by malignant behavior. These ICD-10-CM diagnosis codes are used to document tumor site, malignant behavior, and any local or metastatic spread, capturing disease severity, organ involvement, or clinical complexity relevant to this group. Accurate coding within the ICD-10-CM C7A group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.
Customize your policy alerts
Sign up for ICD-10-CM Code For Malignant Neuroendocrine Tumors: Group Overview policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
ICD-10-CM C7A: Malignant Neuroendocrine Tumors Overview
The International Classification of Diseases, Tenth Revision, Clinical Modification code group C7A represents malignant neuroendocrine tumors arising in various sites where neuroendocrine cells are present. These neoplasms affect endocrine and neuroendocrine tissues and can involve multiple organ systems, including the gastrointestinal tract, pancreas, and lungs. Accurate coding matters for reimbursement because it ensures precise capture of tumor behavior, site, and extent, supporting appropriate claim adjudication and clinical documentation.